Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice

Detalles Bibliográficos
Autores principales: Butler, Javed, Zannad, Faiez, Filippatos, Gerasimos, Anker, Stefan D., Packer, Milton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550194/
https://www.ncbi.nlm.nih.gov/pubmed/32935133
http://dx.doi.org/10.1093/eurheartj/ehaa731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550194/
https://www.ncbi.nlm.nih.gov/pubmed/32935133
http://dx.doi.org/10.1093/eurheartj/ehaa731

Ejemplares similares